Rapid detection of SMARCB1 sequence variation using high resolution melting

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Dagar, Vinod ^a,b   Chow, Chung Wo ^a,b   Ashley, David M ^a,b   Algar, Elizabeth M ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PROTEIN SMARCB1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; NONHISTONE PROTEIN; SMARCB1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; AMPLICON; ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; DNA SEQUENCE; DNA SPLICING; EXON; FRAMESHIFT MUTATION; GENE DELETION; GENETIC CODE; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; LABORATORY TEST; MELTING POINT; MUTATIONAL ANALYSIS; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PROCESS OPTIMIZATION; RHABDOID TUMOR; SEQUENCE ANALYSIS; FREEZING; GENETICS; METHODOLOGY; MUTATION; SENSITIVITY AND SPECIFICITY;

CHROMOSOMAL PROTEINS, NON-HISTONE; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FREEZING; HUMANS; MUTATION; RHABDOID TUMOR; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS;

EID: 74049151955     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-437     Document Type: Article

References (14)

1. Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer research 1999, 59(1):74-79.
2. Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 1998, 394(6689):203-206. 10.1038/28212, 9671307.
3. Judkins AR, Burger PC, Hamilton RL, Kleinschmidt-DeMasters B, Perry A, Pomeroy SL, Rosenblum MK, Yachnis AT, Zhou H, Rorke LB. INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. Journal of neuropathology and experimental neurology 2005, 64(5):391-397.
4. Xiangru Wu VD, Algar E, Muscat A, Bandopadhayay P, Ashley D, Chow CW. Rhabdoid tumour:a malignancy of early childhood with variable primary site, histology and clinical behaviour. Pathology 2008, 40:664-670. 10.1080/00313020802436451, 18985520.
5. Ammerlaan AC, Ararou A, Houben MP, Baas F, Tijssen CC, Teepen JL, Wesseling P, Hulsebos TJ. Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome. British journal of cancer 2008, 98(2):474-479. 10.1038/sj.bjc.6604156, 2361463, 18087273.
6. Biegel JA, Fogelgren B, Wainwright LM, Zhou JY, Bevan H, Rorke LB. Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor. Genes, chromosomes & cancer 2000, 28(1):31-37. 10.1002/(SICI)1098-2264(200005)28:1<31::AID-GCC4>3.0.CO;2-Y, 10738300.
7. Hulsebos TJ, Plomp AS, Wolterman RA, Robanus-Maandag EC, Baas F, Wesseling P. Germline mutation of INI1/SMARCB1 in familial schwannomatosis. American journal of human genetics 2007, 80(4):805-810. 10.1086/513207, 1852715, 17357086.
8. Modena P, Lualdi E, Facchinetti F, Galli L, Teixeira MR, Pilotti S, Sozzi G. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer research 2005, 65(10):4012-4019. 10.1158/0008-5472.CAN-04-3050, 15899790.
9. Sevenet N, Sheridan E, Amram D, Schneider P, Handgretinger R, Delattre O. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. American journal of human genetics 1999, 65(5):1342-1348. 10.1086/302639, 1288286, 10521299.
10. Taylor MD, Gokgoz N, Andrulis IL, Mainprize TG, Drake JM, Rutka JT. Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene. American journal of human genetics 2000, 66(4):1403-1406. 10.1086/302833, 1288204, 10739763.
11. Wittwer CT, Reed GH, Gundry CN, Vandersteen JG, Pryor RJ. High-resolution genotyping by amplicon melting analysis using LCGreen. Clinical chemistry 2003, 49(6 Pt 1):853-860. 10.1373/49.6.853, 12765979.
12. Fujisawa H, Takabatake Y, Fukusato T, Tachibana O, Tsuchiya Y, Yamashita J. Molecular analysis of the rhabdoid predisposition syndrome in a child: a novel germline hSNF5/INI1 mutation and absence of c-myc amplification. Journal of neuro-oncology 2003, 63(3):257-262. 10.1023/A:1024345221792, 12892231.
13. Hadfield KD, Newman WG, Bowers NL, Wallace A, Bolger C, Colley A, McCann E, Trump D, Prescott T, Evans DG. Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis. Journal of medical genetics 2008, 45(6):332-339. 10.1136/jmg.2007.056499, 18285426.
14. Janson K, Nedzi LA, David O, Schorin M, Walsh JW, Bhattacharjee M, Pridjian G, Tan L, Judkins AR, Biegel JA. Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation. Pediatric blood & cancer 2006, 47(3):279-284. 10.1002/pbc.20622, 16261613.